Feed

Show only
19/11/2020
CMS ad­vises Kien­zle Auto­mot­ive on sale to Liberta Part­ners
Düs­sel­dorf – Liberta Part­ners, a multi-fam­ily hold­ing com­pany, has ac­quired Kien­zle Auto­mot­ive GmbH in the course of a suc­ces­sion part­ner­ship via Liberta Part­ners Fund II. Kien­zle Auto­mot­ive is a lead­ing...
09 November 2020
CMS Ex­pert Guide to mo­bile work­ing
Al­though chal­lenges brought on by the pan­dem­ic vary from coun­try to coun­try, COV­ID-19 has changed the way we work and do busi­ness. The situ­ation has also raised ques­tions: Will the pan­dem­ic's im­pact be...
Comparable
26 November 2020
European Eth­ics, Com­pli­ance & In­teg­rity For­um
The For­um aims to gath­er prac­ti­tion­ers, clerks, sci­ent­ists in 9 dif­fer­ent them­at­ic ses­sions linked to eth­ics, com­pli­ance & in­teg­rity. With al­most 50 Speak­ers from all over Europe we will dis­cuss cur­rent...
23 November 2020
EU high court con­firms CBD is not a nar­cot­ic
In a long-awaited rul­ing, the European Court of Justice (ECJ) cla­ri­fied that the can­nabis act­ive in­gredi­ent Can­na­bi­d­i­ol (CBD) is not to be clas­si­fied as a nar­cot­ic. France sub­mits ques­tion on CBD in e-ci­gar­ettes...
17/11/2020
CMS ad­vises bi­otech com­pany Cherry Bio­labs on ex­clus­ive li­cence agree­ment...
Mu­nich – Bi­otech com­pany Cherry Bio­labs, a spin-off from Würzburg Uni­versity Hos­pit­al and an ex­clus­ive li­censee of Ju­li­us-Max­imili­ans-Uni­versity in Würzburg, has signed an ex­clus­ive sub-li­cence agree­ment...
27 October 2020
CMS Ex­pert Guide on sexu­al har­ass­ment in the work­place
Wel­come to our CMS Ex­pert Guide on sexu­al har­ass­ment in the work­place. How dif­fer­ent coun­tries re­spon­ded to the #MeT­oo move­ment and how the law reg­u­lates work­place har­ass­ment on a glob­al scale were key...
Comparable
01 December 2020
The Fu­ture is Now: The New World of Work
As coun­tries con­tin­ue to struggle with COV­ID-19 while also try­ing to re­tain at least a semb­lance of busi­ness as usu­al, the way we work has been changed ex­tens­ively, in some re­spects po­ten­tially forever.The...
20 November 2020
United States Sen­ate passes Anti-Dop­ing Le­gis­la­tion
On 16 Novem­ber 2020, the United States Sen­ate passed le­gis­la­tion that would al­low the pro­sec­u­tion in the US of dop­ing of­fences at in­ter­na­tion­al sport­ing events in which Amer­ic­an ath­letes, spon­sors, or...
17 November 2020
CMS Dis­putes Talk
In these un­cer­tain times, glob­al busi­nesses in al­most every sec­tor are fa­cing chal­lenges brought about by an un­pre­ced­en­ted op­er­a­tion­al cli­mate. Ac­tions and de­cisions taken dur­ing and im­me­di­ately after...
07 October 2020
CMS Ex­pert Guide to the private place­ment of equity se­cur­it­ies
One of the most com­mon ques­tions we are asked across CMS in our Equity Cap­it­al Mar­ket prac­tice is what are the rules about ap­proach­ing a lim­ited num­ber of in­vestors in dif­fer­ent jur­is­dic­tions, in re­la­tion...
Comparable
18 November 2020
COV­ID-19: European Com­mis­sion ex­tends cer­tain sup­port meas­ures for the...
In May 2020, the Com­mis­sion ad­op­ted a series of meas­ures amend­ing cer­tain con­di­tions of the Reg­u­la­tion No. 1008/2008 on com­mon rules for the op­er­a­tion of air ser­vices in the Com­munity and of the Dir­ect­ive...
10/11/2020
CMS ad­vises An­chor part­ner To­bi­as Wahl on sale of Gehring Tech­no­lo­gies...
Stut­tgart – In­solv­ency ad­min­is­trat­or To­bi­as Wahl and his team from An­chor Recht­san­wälte and An­chor Man­age­ment have suc­ceeded in find­ing a buy­er for the Gehring en­gin­eer­ing group. The Na­gel Group will...